| Financial Year |
March 31 2023 |
| Monetary Funds |
4,599,471,091.86 |
| Held-for-trading Financial Assets |
54,334,233.21 |
| Notes Receivable |
211,161,468.79 |
| Accounts Receivable |
1,117,193,176.60 |
| Advances to Suppliers |
111,608,956.32 |
| Other Receivables |
167,430,260.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,460,310,976.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
326,444,797.07 |
| Total Current Assets |
9,571,037,011.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
157,318,226.78 |
| Investment Properties |
1,408,712.91 |
| Fixed Assetes |
6,111,422,474.63 |
| Under-construction Projects |
2,497,613,817.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
416,285,987.84 |
| R&D expenses |
1,694,737.07 |
| Goodwill |
4,387,401.63 |
| Long-Term Deferred and Prepaid Expenses |
62,815,923.42 |
| Deferred Income Tax Assets |
182,458,401.63 |
| Other Non-Current Assets |
255,439,095.63 |
| Sub-Total of Non-Current Assets |
9,851,727,475.95 |
| Total Assets |
19,422,764,487.16 |
| Short-Term Loans |
577,529,669.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,261,832,553.82 |
| Accounts Payable |
1,772,579,725.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,740,652.66 |
| Taxes Payable |
46,543,241.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,911,431.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
666,639,031.22 |
| Other Current Liabilities |
175,599,051.63 |
| Sub-Total of Current Liabilities |
6,473,805,366.97 |
| Long-term Loans |
3,491,319,528.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
22,160,239.99 |
| Deferred Income Tax Liabilities |
19,065,840.47 |
| Other Non-Current Liabilities |
589,729,541.40 |
| Sub-Total of Non-Current Liabilities |
4,631,449,717.05 |
| Total Liabilities |
11,105,255,084.02 |
| Paid-In Capital(Or Share Stock) |
766,023,589.00 |
| Capital Surplus |
2,698,970,818.94 |
| Surplus Reserve |
407,539,525.38 |
| LESS:Treasury Stock |
212,173,764.00 |
| Undistributed Profits |
2,779,399,528.38 |
| Minority Stockholder's Interest |
1,893,942,841.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,423,566,561.79 |
| Owner's Equity（Stockholder's Equity） |
8,317,509,403.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,422,764,487.16 |
